United Kingdom· GB-APID-39042911000001102
Jyseleca 200mg tablets
A filgotinib product containing filgotinib, registered in United Kingdom by Alfasigma UK Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Filgotinib is registered in 10 of 19 countries.
Countries holding a registration under ATC L04AF04 (filgotinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Filgotinib · ATC L04AF04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Filgotinib
- Manufacturer
- Alfasigma UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AF04
- ATC class
- Filgotinib
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin05391507146304
- gtin05430002329109
- gtin05430002329086
- gtin08020030001602
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Filgotinib in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJYSELECAAlfasigma S.p.A., Bologna
- FinlandJyselecaOrifarm Oy
- FranceJYSELECA 100 mg, comprimé pelliculéALFASIGMA (ITALIE)
- SwedenJyseleca 100 mg Filmdragerad tablettAlfasigma S.P.A.
- SpainJYSELECA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAlfasigma S.P.A.
- BelgiumJyseleca 100 mgAlfasigma
- IrelandJyseleca 100 mg film-coated tabletsAlfasigma S.p.A
- IcelandJyselecaAlfaSigma S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jyseleca
- Liechtenstein · Jyseleca
- Norway · Jyseleca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6ef2afa-ecce-4b1e-8d1c-2440a25b1bcd GET /v1/drugs/c6ef2afa-ecce-4b1e-8d1c-2440a25b1bcd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39042911000001102",
"desc": "Jyseleca 200mg tablets (Alfasigma UK Ltd)",
"form": "Oral tablet",
"vpid": "39046311000001104",
"source": "dmd",
"vtm_id": "1287489002",
"strength": "200 mg",
"substance": "Filgotinib",
"ingredient": "Filgotinib maleate",
"supplier_code": "40483411000001104"
}See everything about filgotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.